A call from women living with the condition
The Polyendocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging the government to list GLP-1 drugs on the PBS for people living with PMOS, along with more funding for evidence-based research.
Lorna Berry, a POSAA spokesperson who was diagnosed with the condition at 32, said some women were already missing out on the medications because of their high cost, which can set patients back several hundred dollars a month.
It's important for people to have access to medications, irrespective of where they live or where they were born … it's really important that there's equitable access.
PMOS: a condition with a new name
PMOS, formerly known as polycystic ovary syndrome, is a lifelong condition with no cure. Its main symptoms and risks include:
- Irregular periods, one of the most common signs.
















